Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

LIQUIBAND FIX8® for Ventral Incisional Hernia

NCT: NCT07295379 · ACTIVE_NOT_RECRUITING

NCT IDNCT07295379
StatusACTIVE_NOT_RECRUITING
Start Date2026-02-02
Completion2026-07-30
SponsorAdvanced Medical Solutions Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

This study is designed to evaluate the safety and performance of device LiquiBand FIX8 Open hernia mesh fixation device. The use of this device is not experimental, as it is already approved for use in the EU (CE-marked). This is a retrospective post market clinical follow-up study to collect information about the use of the device in a real-world setting for ventral incisional hernia repair. Ventral incisional hernias occur following surgery and the most common method of treatment includes implanting a mesh, which in the case of ventral incisional hernia, the standard of care is intra-peritoneal onlay mesh. This is fixed in place using sutures, tacks or adhesive. The LiquiBand FIX8 Open device is an atraumatic device specifically engineered for strong mesh fixation of hernia repair meshes. Hernia repair meshes are woven sheets of flexible synthetic plastic which are placed tension-free over the weakness in the peritoneum abdominal wall, essentially 'plugging' it up. Tension is created in the abdominal wall during repair, but the mesh allows this tension to be spread out. The mesh must be secured to the underlying tissue and this is often done with the use of tacks or sutures, however, the study device instead uses a glue (N-Butyl 2 cyanoacrylate adhesive) to secure the mesh. The FIX8 Open device is designed for the application of this glue to the implanted hernia repair mesh in order to fix the mesh to the underlying tissue. When the glue is applied to the mesh and tissue, it polymerises (forms a chemical bond) due to the moisture on the tissue surface within approximately 10 seconds and allows the mesh to remain in the correct position. The study device can also be used to close topical wounds (the opening that the surgeon makes on the surface to access the hernia).

Frequently Asked Questions

What is LIQUIBAND FIX8® for Ventral Incisional Hernia?

LIQUIBAND FIX8® for Ventral Incisional Hernia is a clinical trial registered under NCT07295379. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07295379?

The current status of NCT07295379 (LIQUIBAND FIX8® for Ventral Incisional Hernia) is: ACTIVE_NOT_RECRUITING.

When did LIQUIBAND FIX8® for Ventral Incisional Hernia start?

LIQUIBAND FIX8® for Ventral Incisional Hernia started on 2026-02-02.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.